• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[经导管主动脉瓣置换术后的冠状动脉阻塞。风险评估与预防策略]

[Coronary obstruction following transcatheter aortic valve replacement. Risk evaluation and preventive strategies].

作者信息

Arévalos Víctor, Spione Francesco, Vela Paula, Iacovelli Fortunato, Sanchis Laura, Freixa Xavier, Brugaletta Salvatore, Tesorio Tullio, Altisent Omar Abdul-Jawad, Sabaté Manel, Regueiro Ander

机构信息

Departamento de Cardiología, Institut Clinic Cardiovascular, Hospital Clinic, Barcelona, España Departamento de Cardiología Institut Clinic Cardiovascular Hospital Clinic Barcelona España.

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, España Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Universitat de Barcelona Barcelona España.

出版信息

REC Interv Cardiol. 2024 Feb 5;6(2):117-126. doi: 10.24875/RECIC.M23000428. eCollection 2024 Apr-Jun.

DOI:10.24875/RECIC.M23000428
PMID:40416347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12097366/
Abstract

Coronary obstruction (CO) is a rare but potentially fatal complication of transcatheter aortic valve implantation (TAVI). The present article aims to summarize the evidence on CO risk factors and provide an overview of preventive strategies. We performed a comprehensive literature review focused on these items. The analysis included studies addressing patient-specific characteristics, procedural aspects, and the effectiveness of various prevention techniques in mitigating CO risk. Specific risk factors for CO, which can be assessed by evaluating patient characteristics using computed tomography, are described. Procedural factors associated with an increased risk of CO are discussed. Preventive techniques, including the chimney stent and bioprosthetic aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA), are also described, highlighting the advantages and disadvantages of each method. The present review also provides an overview of emerging dedicated devices designed to address this complication. In conclusion, identifying patients at risk for CO is crucial for optimizing TAVI outcomes. Comprehensive imaging assessment and appropriate preventive strategies, such as the BASILICA technique, can mitigate the risk of CO and improve patient outcomes. Further research is needed to validate emerging dedicated devices.

摘要

冠状动脉阻塞(CO)是经导管主动脉瓣植入术(TAVI)一种罕见但可能致命的并发症。本文旨在总结CO危险因素的证据,并概述预防策略。我们针对这些项目进行了全面的文献综述。分析包括针对患者特定特征、手术操作方面以及各种预防技术在降低CO风险方面有效性的研究。描述了可通过计算机断层扫描评估患者特征来评估的CO特定危险因素。讨论了与CO风险增加相关的手术因素。还描述了预防技术,包括烟囱支架和生物人工主动脉瓣叶有意撕裂以预防医源性冠状动脉阻塞(BASILICA),强调了每种方法的优缺点。本综述还概述了为解决这一并发症而设计的新型专用装置。总之,识别有CO风险的患者对于优化TAVI结果至关重要。全面的影像评估和适当的预防策略,如BASILICA技术,可以降低CO风险并改善患者预后。需要进一步研究来验证新型专用装置。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/6ad31c492c1b/2604-7306-recic-6-2-117-en-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/2197c0367b54/2604-7306-recic-6-2-117-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/0bc9961b8136/2604-7306-recic-6-2-117-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/75a9458479ad/2604-7306-recic-6-2-117-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/61faf1f7ce8e/2604-7306-recic-6-2-117-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/362c78c86f1d/2604-7306-recic-6-2-117-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/4f8e61ef85f2/2604-7306-recic-6-2-117-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/2a25dfba95fe/2604-7306-recic-6-2-117-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/5087e3ba1b1c/2604-7306-recic-6-2-117-en-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/91c060812591/2604-7306-recic-6-2-117-en-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/65092fd83fba/2604-7306-recic-6-2-117-en-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/18e1beec7f11/2604-7306-recic-6-2-117-en-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/64d5f457e191/2604-7306-recic-6-2-117-en-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/bfb34948b357/2604-7306-recic-6-2-117-en-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/6ad31c492c1b/2604-7306-recic-6-2-117-en-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/2197c0367b54/2604-7306-recic-6-2-117-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/0bc9961b8136/2604-7306-recic-6-2-117-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/75a9458479ad/2604-7306-recic-6-2-117-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/61faf1f7ce8e/2604-7306-recic-6-2-117-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/362c78c86f1d/2604-7306-recic-6-2-117-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/4f8e61ef85f2/2604-7306-recic-6-2-117-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/2a25dfba95fe/2604-7306-recic-6-2-117-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/5087e3ba1b1c/2604-7306-recic-6-2-117-en-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/91c060812591/2604-7306-recic-6-2-117-en-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/65092fd83fba/2604-7306-recic-6-2-117-en-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/18e1beec7f11/2604-7306-recic-6-2-117-en-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/64d5f457e191/2604-7306-recic-6-2-117-en-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/bfb34948b357/2604-7306-recic-6-2-117-en-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e7/12097366/6ad31c492c1b/2604-7306-recic-6-2-117-en-gf7.jpg

相似文献

1
[Coronary obstruction following transcatheter aortic valve replacement. Risk evaluation and preventive strategies].[经导管主动脉瓣置换术后的冠状动脉阻塞。风险评估与预防策略]
REC Interv Cardiol. 2024 Feb 5;6(2):117-126. doi: 10.24875/RECIC.M23000428. eCollection 2024 Apr-Jun.
2
Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: the Hamburg BASILICA experience.在接受经导管主动脉瓣植入术的高危患者中预防冠状动脉阻塞:汉堡 BASILICA 经验。
Clin Res Cardiol. 2021 Dec;110(12):1900-1911. doi: 10.1007/s00392-021-01881-4. Epub 2021 Jun 22.
3
Balloon-Augmented Leaflet Modification With Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction and Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction: Benchtop Validation and First In-Man Experience.球囊增强瓣叶成形术,应用于生物瓣或自体主动脉瓣叶的有意图撕裂,以预防医源性冠状动脉阻塞和前二尖瓣叶撕裂导致的流出道阻塞:台架验证和首例人体应用经验。
Circ Cardiovasc Interv. 2021 Nov;14(11):e011028. doi: 10.1161/CIRCINTERVENTIONS.121.011028. Epub 2021 Oct 22.
4
Chimney Stenting vs BASILICA for Prevention of Acute Coronary Obstruction During Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术中预防急性冠状动脉阻塞的烟囱支架与 BASILICA 比较。
JACC Cardiovasc Interv. 2024 Mar 25;17(6):742-752. doi: 10.1016/j.jcin.2024.01.007.
5
The BASILICA Trial: Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction.BASILICA 试验:旨在通过主动撕裂瓣叶预防 TAVR 冠状动脉阻塞的前瞻性多中心研究。
JACC Cardiovasc Interv. 2019 Jul 8;12(13):1240-1252. doi: 10.1016/j.jcin.2019.03.035. Epub 2019 Jun 12.
6
Safeguards and pitfalls for Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction during transcatheter aortic valve replacement-the BASILICA technique.生物假体或天然主动脉瓣叶有意撕裂以预防经导管主动脉瓣置换术中医源性冠状动脉阻塞的保障措施和陷阱——BASILICA技术
Ann Cardiothorac Surg. 2021 Sep;10(5):700-707. doi: 10.21037/acs-2021-tviv-26.
7
The Use of BASILICA Technique to Prevent Coronary Obstruction in a TAVI-TAVI Procedure.在经导管主动脉瓣置换术(TAVI)-经导管主动脉瓣置换术过程中使用BASILICA技术预防冠状动脉阻塞。
J Clin Med. 2021 Nov 26;10(23):5534. doi: 10.3390/jcm10235534.
8
Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human.经导管主动脉瓣叶撕裂术预防经导管主动脉瓣置换术中冠状动脉阻塞:概念到首例人体。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):677-689. doi: 10.1016/j.jcin.2018.01.247.
9
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: From Computed Tomography to BASILICA.经导管主动脉瓣置换术中预防冠状动脉阻塞:从计算机断层扫描到 BASILICA。
JACC Cardiovasc Interv. 2019 Jul 8;12(13):1197-1216. doi: 10.1016/j.jcin.2019.04.052.
10
Numerical models of valve-in-valve implantation: effect of intentional leaflet laceration on the anchorage.经导管主动脉瓣置换术中瓣中瓣植入的数值模型:人工撕裂瓣叶对锚定的影响。
Biomech Model Mechanobiol. 2020 Apr;19(2):415-426. doi: 10.1007/s10237-019-01218-1. Epub 2019 Aug 30.

引用本文的文献

1
Individualized Selection of Valve Intervention Strategies in Aortic Disease Is Key for Better Outcomes.主动脉疾病中瓣膜干预策略的个体化选择是取得更好治疗效果的关键。
J Pers Med. 2025 Aug 1;15(8):337. doi: 10.3390/jpm15080337.

本文引用的文献

1
Safety and efficacy of the BASILICA technique in patients at high risk of coronary obstruction undergoing TAVI.BASILICA技术在接受经导管主动脉瓣置入术(TAVI)且存在冠状动脉阻塞高风险患者中的安全性和有效性。
Rev Esp Cardiol (Engl Ed). 2024 Feb;77(2):181-183. doi: 10.1016/j.rec.2023.08.012. Epub 2023 Nov 4.
2
Predicted vs Observed Valve to Coronary Distance in Valve-in-Valve TAVR: A Computed Tomography Study.经导管主动脉瓣置换术中瓣叶至冠状动脉距离的预测与观察:一项 CT 研究。
JACC Cardiovasc Interv. 2023 Aug 28;16(16):2021-2030. doi: 10.1016/j.jcin.2023.05.038. Epub 2023 Jul 19.
3
Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry.
经导管主动脉瓣置换术后的冠状动脉阻塞:来自西班牙 TAVI 注册研究的见解。
JACC Cardiovasc Interv. 2023 May 22;16(10):1208-1217. doi: 10.1016/j.jcin.2023.03.024.
4
Predicting Coronary Obstruction After TAVR: Better Safe Than Sorry.经导管主动脉瓣置换术后冠状动脉阻塞的预测:宁求稳妥,毋留遗憾。
JACC Cardiovasc Interv. 2023 Feb 27;16(4):426-428. doi: 10.1016/j.jcin.2023.01.013.
5
Coronary Obstruction From TAVR in Native Aortic Stenosis: Development and Validation of Multivariate Prediction Model.经导管主动脉瓣置换术治疗主动脉瓣狭窄时发生的冠状动脉阻塞:多变量预测模型的建立和验证。
JACC Cardiovasc Interv. 2023 Feb 27;16(4):415-425. doi: 10.1016/j.jcin.2022.11.018.
6
First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement.用于经导管主动脉瓣置换术中预防冠状动脉阻塞的首例人体专用瓣叶劈开装置
JACC Cardiovasc Interv. 2023 Jan 9;16(1):94-102. doi: 10.1016/j.jcin.2022.10.050.
7
First-in-Human Undermining Iatrogenic Coronary Obstruction With Radiofrequency Needle (UNICORN) Procedure During Valve-in-Valve Transcatheter Aortic Valve Replacement.在经导管主动脉瓣置换术的瓣中瓣手术中应用射频针进行首例人体医源性冠状动脉阻塞破坏(UNICORN)手术。
Circ Cardiovasc Interv. 2022 Nov;15(11):928-931. doi: 10.1161/CIRCINTERVENTIONS.122.012399. Epub 2022 Oct 21.
8
Commissural Versus Coronary Optimized Alignment During Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术中交界区与冠状动脉优化对准。
JACC Cardiovasc Interv. 2022 Jan 24;15(2):135-146. doi: 10.1016/j.jcin.2021.10.005.
9
Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review.经导管主动脉瓣置换术治疗先前植入的经导管瓣膜结构退变(TAVR-in-TAVR):一项系统评价
Eur J Cardiothorac Surg. 2022 May 2;61(5):967-976. doi: 10.1093/ejcts/ezab443.
10
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.